CLINICAL_TRIALS
trial_result
· 2025-07-03
Clinical Trial Update: A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain [Phase 2]
Summary
A Phase 2 clinical trial evaluating LY3556050 in adults with diabetic peripheral neuropathy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetic Peripheral Neuropathy | Phase 2 | Status: COMPLETED